Larimar Therapeutics, Inc. (LRMR)

NASDAQ: LRMR · Real-Time Price · USD

4.370

+0.060 (1.39%)

At close: Aug 12, 2026, 4:00 PM EDT

4.370

0.00 (0.00%)

After-hours: Aug 12, 2026, 5:13 PM EDT

Larimar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	92.69	85.41	33.22	26.75	26.83	70.1
Short-Term Investments	63.58	51.44	150.24	60.04	91.6	-
Cash & Short-Term Investments	156.27	136.85	183.45	86.79	118.43	70.1
Cash Growth	12.81%	-25.40%	111.38%	-26.71%	68.95%	-24.33%
Other Current Assets	4.41	5.17	11.85	3.39	2.31	2.11
Total Current Assets	160.67	142.02	195.3	90.18	120.74	72.2
Net Property, Plant & Equipment	3.69	2.69	3.72	3.76	3.69	4.46
Other Long-Term Assets	0.94	1.13	1.2	2	1.98	2.01
Total Assets	165.3	145.84	200.23	95.94	126.41	78.67
Accounts Payable	7.6	5.22	2.42	1.28	1.69	1.66
Accrued Expenses	25.37	58.47	20.87	7.39	8.41	6.59
Current Portion of Leases	1.2	1.11	1.06	0.84	0.61	0.59
Total Current Liabilities	34.17	64.8	24.36	9.51	10.71	8.85
Long-Term Leases	3.75	2.96	4.06	4.71	4.8	5.41
Total Long-Term Liabilities	3.75	2.96	4.06	4.71	4.8	5.41
Total Liabilities	37.92	67.76	28.41	14.22	15.5	14.25
Common Stock	0.1	0.08	0.06	0.04	0.04	0.02
Additional Paid-in Capital	624.52	512.78	440.76	270.15	262.5	180.65
Accumulated Other Comprehensive Income	-0.01	0.05	0.15	0.08	-0.03	-
Retained Earnings	-	-434.83	-269.16	-188.55	-151.61	-116.25
Shareholders' Equity	127.38	78.09	171.81	81.72	110.9	64.41
Total Liabilities & Equity	165.3	145.84	200.23	95.94	126.41	78.67
Total Debt	4.96	4.07	5.12	5.55	5.41	6
Net Cash (Debt)	151.31	132.79	178.34	81.24	113.02	64.1
Net Cash Growth	13.00%	-25.54%	119.51%	-28.12%	76.33%	-25.58%
Net Cash Per Share	1.69	1.82	2.91	1.85	4.39	3.73
Book Value	127.38	78.09	171.81	81.72	110.9	64.41
Book Value Per Share	1.43	1.07	2.80	1.86	4.31	3.75
Tangible Book Value	127.38	78.09	171.81	81.72	110.9	64.41
Tangible Book Value Per Share	1.43	1.07	2.80	1.86	4.31	3.75

SEC Filings: 10-K · 10-Q